Acute Flaccid Myelitis

In recent years, a novel form of acquired paralysis with a pattern of increased incidence biennially has been noted in children.  Following the Center for Disease Control’s guidance in 2014 and 2016, this form of paralysis was termed Acute Flaccid Myelitis (AFM). AFM demonstrates a unique clinical presentation of motor paralysis frequently including the respiratory system but with preservation of the sensory system. Medical professionals likened the clinical presentation to polio-like symptoms. However, with a majority of today’s medical professions not having participated in post-polio rehabilitation, as well as recent advancements in the medical field, education, intervention guidance and prognostic information is needed.

  • National and international articles have outlined preliminary characteristics and medical interventions addressing AFM including: Matesanz et al 2019 (1), Kirolos et al 2018 (2), and Theroux et al 2019 (3).
  • Additionally, one article provides a summary of clinical short- and long-term outcomes: Martin et al 2017. (4)
  • Even with this emerging scientific evidence, caregiver concerns, reported in Bove et al 2019 (5), show gaps/needs for diagnostic care, improved intervention efficacy and education for prognosis and recovery. We are hopeful that these articles may assist in preparing healthcare providers for treating children with AFM.

Articles selected by:

  • Laura Argetsinger, DPT, Frazier Rehab Institute, Pediatric NeuroRecovery, University of Louisville, Louisville, KY
  • Michael Sweeny, MD, Pediatric Neurologist, Dept. of Pediatric Neurology, University of Louisville, Louisville, KY